Literature DB >> 26718036

2 The family of protein arginine metkyltransferases.

Mark T Bedford1.   

Abstract

Arginine methylation is a widespread posttranslational modification found on both nuclear and cytoplasmic proteins. The methylation of arginine residues is catalyzed by the protein arginine N-methyltransferase (PRMT) family of enzymes, of which there are at least nine members in mammals. PRMTs are evolutionarily conserved and are foundin organisms from yeast to man, but not in bacteria. Proteins that are arginine methylated are involved in a number of different cellular processes, including transcriptional regulation, RNA metabolism, and DNA damage repair. How arginine methylation impacts these cellular actions is unclear, although it is likely through the regulation of protein-protein and protein-DNA/RNA interactions. The different PRMTs display varying degrees of substrate specificity, and a certain amount of redundancy is likely to exist between different PRMT family members. Most PRMTs methylate glycine- and arginine-rich patches within their substrates. These regions have been termed GAR motifs. The complexity of the methylarginine mark is enhanced by the ability of this residue to be methylated in three different fashions on the guanidino group (with different functional consequences for each methylated state): monomethylated, symmetrically dimethylated, and asymmetrically dimethylated. This chapter outlines the biochemistry of arginine methylation, including a detailed description of the enzymes involved, the motifs methylated, and the prospects of inhibiting these enzymes with small molecules.
Copyright © 2006 Elsevier Inc. All rights reserved.

Entities:  

Year:  2007        PMID: 26718036     DOI: 10.1016/S1874-6047(06)80004-1

Source DB:  PubMed          Journal:  Enzymes        ISSN: 1874-6047


  1 in total

1.  Purification and Identification of Natural Inhibitors of Protein Arginine Methyltransferases from Plants.

Authors:  Zhengxin Wang; Ling Xiong; Quanbo Xiong
Journal:  Mol Cell Biol       Date:  2022-03-21       Impact factor: 5.069

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.